metallothionein (NeuroScientific)

N/A

Report date: 2025/01/26 16:18:35

Base Information

Drug Namemetallothionein (NeuroScientific)
Drug Alias Namechelating agent (Neurosciences Victoria/University of Tasmania)free radical scavenger (Neurosciences Victoria/University of Tasmania)metallothionein (Alzhyme)metallothionein (Neurosciences Victoria/University of Tasmania)metallothionein analogs (Neurosciences Victoria/University of Tasmania) +[7] 
ClassificationNatural product/ExtractBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMetallothionein modulatorsFree radicals scavengers
TargetsMetallothioneinFree radicals
Therapy Area/IndicationsNerve DegenerationSpinal Cord InjuriesAlzheimer Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Tasmania
China Registration ClassN/A

Develop Information

Active CompaniesNeuroScientific Biopharmaceuticals Ltd
Inactive CompaniesNeurosciences Victoria LtdUniversity of Tasmania
Active IndicationsAlzheimer DiseaseMultiple Sclerosis
Inactive IndicationsNerve DegenerationSpinal Cord InjuriesBrain Injuries

Other Information

ATC CodeN/A
Related LinksN/A